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Abstract
The effects of acute pulmonary coexposures to silica and diesel particulate matter (DPM), which 
may occur in various mining operations, were investigated in vivo. Rats were exposed by 
intratracheal instillation (IT) to silica (50 or 233 μg), DPM (7.89 or 50 μg) or silica and DPM 
combined in phosphate-buffered saline (PBS) or to PBS alone (control). At one day, one week, 
one month, two months and three months postexposure bronchoalveolar lavage and histopathology 
were performed to assess lung injury, inflammation and immune response. While higher doses of 
silica caused inflammation and injury at all time points, DPM exposure alone did not. DPM (50 
mg) combined with silica (233 μg) increased inflammation at one week and one-month 
postexposure and caused an increase in the incidence of fibrosis at one month compared with 
exposure to silica alone. To assess susceptibility to lung infection following coexposure, rats were 
exposed by IT to 233 mg silica, 50 μg DPM, a combination of the two or PBS control one week 
before intratracheal inoculation with 5 105 Listeria monocytogenes. At 1, 3,5, 7 and 14 days 
following infection, pulmonary immune response and bacterial clearance from the lung were 
evaluated. Coexposure to DPM and silica did not alter bacterial clearance from the lung compared 
to control. Although DPM and silica coexposure did not alter pulmonary susceptibility to infection 
in this model, the study showed that noninflammatory doses of DPM had the capacity to increase 
silica-induced lung injury, inflammation and onset/incidence of fibrosis.
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Introduction
The natural gas and oil industry is one of the most rapidly growing industries in the United 
States. Specifically, the industry is expanding in the area of hydraulic fracturing, “fracking,” 
or horizontal drilling. This process extracts natural resources from otherwise inaccessible 
deposits below the earth’s surface, provided more than two million jobs in 2012 and is 
estimated to support approximately four million jobs by 2025 (API, 2014). Two respirable 
particulates identified as possible exposure hazards in fracking workplaces include diesel 
particulate matter (DPM) and a-quartz crystalline silica (SiO2) (Breitenstein et al., 2011). 
These two particulates are also present in combination in other mining operations including 
below ground mining operations, particularly in coal extraction. Although toxicity of these 
two particulates have been studied in detail as individual exposures, there are currently no in 
vivo studies, as far as we are aware, that have examined the pulmonary effects of the 
particulates in combination at doses that are relevant to various mining operations.
In addition to underground mining operations and operations in hydraulic fracturing, where 
significant numbers of diesel engines are utilized (transport, drilling and pumping), diesel 
exhaust (DE) exposure is also prevalent in industries including trucking and railroad 
operations (OSHA/MSHA, 2013). DE is a highly complex mixture of chemical substances 
but is primarily composed of an elemental carbon (EC) core having additional organic 
carbon constituents adsorbed to it. Other than the EC components, compounds typically 
contained in DE include:polyaromatic hydrocarbons (PAHs), sulfates, silicates, nitrates, as 
well as metallic particulates (OSHA/MSHA, 2013). DPM exposure is linked to a variety of 
adverse health outcomes, including enhanced sensitization to allergic stimulus, development 
and aggravation of asthma, chronic bronchitis, decreased lung function, airway 
inflammation, decreased vascular function and development of cancers, as reported in 
epidemiological studies (Beatty & Shimshack, 2011; Diaz-Sanchez et al., 1999; Gauderman 
et al., 2004; Garshick et al., 2004;Kachuri et al., 2016; Lucking et al., 2011;McCreanor et al. 
2007; Nightingale et al., 2000). Based on these studies, DE and DPM have been identified 
by the International Agency for Cancer Research (IARC) as a group 1 carcinogen (IARC, 
2012; OSHA/MSHA, 2013). In addition to human cohort studies, studies involving healthy 
human volunteers exposed to DE/DPM in a controlled chamber have also shown that 
DE/DPM caused pulmonary inflammation in acute exposure scenarios (Nightingale et al., 
2000; Salvi et al., 1999). Controlled human studies as reviewed by Ghio et al. (Ghio et al., 
2012a,b) show that inflammation occurs in the respiratory tract of humans exposed to DPM 
and that this occurs in a dose-dependent manner. DPM toxicity has also been investigated in 
vivo and in vitro. DPM has been shown to enhance airway reactivity, inflammation, 
production of reactive oxygen species (ROS) and increased development and severity of 
allergic asthma, lung fibrosis, lung injury, alveolar edema, lung cancer and mortality in 
exposed animals (Brandt et al., 2013, 2015; Ichinose et al., 1995; Kim et al., 2016; Ma & 
Ma, 2002; Madden et al., 2000;Mauderly et al., 1994;Sagai et al., 1993; Singh et al., 2004; 
Zhao et al., 2009). Studies conducted in vitro suggest, similarly, that DPM contributes to 
airway inflammation, production of reactive oxidants, unfolded protein response, allergic 
response, decreased mucociliary clearance and upregulation of cancer-associated proteins in 
lung cells (Abe et al., 2000;Bayram et al., 1998; Jung et al., 2007; Le Vee et al., 
Farris et al. Page 2
Inhal Toxicol. Author manuscript; available in PMC 2019 June 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
2016;Ohtoshi et al., 1998;Sagai et al., 1993, 1996;Totlandsdal et al., 2015;Vattanasit et al., 
2014; Zhou et al., 2015). Furthermore, DPM has been shown to alter the pulmonary immune 
function and is associated with increased susceptibility to infection (Castranova et al., 2001; 
Ma & Ma, 2002;Mundandhara et al, 2006;Pierdominici et al., 2014;Provoost et al., 2010; 
Siegel et al., 2004;Steerenberg et al., 1998; Yin et al., 2002).
Several countries have regulations to control occupational exposure to DE or DPM. These 
regulations vary relative to underground mining operations versus above-ground mining and 
nonmining workplaces. In addition, exposure is differentially regulated by DE constituents 
(total particle, elemental carbon, nitrogen) (HSE, 2012; QDNRM, 2014; OSHA/MSHA, 
2013; SUVA, 2013). In the United States, recommended exposure limits (REL) exist for 
many of the components of DE as individual emissions; however, there is currently no 
Occupational Safety and Health Administration (OSHA) regulation of DPM in nonmining, 
occupational settings. The Mine Safety and Health Administration (MSHA) REL for DE and 
DPM in underground mine operations is a time-weighted average (TWA), based on an 8-h 
work day, of 160 μg/μ3 total carbon, which includes DPM as elemental carbon. Additionally, 
the California Department of Health Services (CDHS) has recommended an occupational 
exposure limit (OEL) of 20 mg/m3 elemental carbon (CDHS, 2002). Both Switzerland and 
Australia have set OELs at 100 μg/μ3 elemental carbon (QDNRM, 2014; TERA, 2014).
Workplace exposure to SiO2 also occurs in a multitude of occupations and are well 
documented for a variety of mining operations, as well as in masonry, painting, sand 
blasting, construction, demolition and ceramics (Beckett et al., 1997; Yassin et al., 2005). 
SiO2 is one of the most common minerals occurring in the earth’s crust and is a major 
component of sand. Sand that contains SiO2 is the primary proppant, or substance used to 
stabilize the fracture during hydraulic fracturing operations and subsequent resource 
extraction. A respirable fraction of this sand can become airborne when transported onto/
around fracking sites or pumped at high volumes/pressure into the well-bore (Esswein et al., 
2013). The respiratory toxicity of the crystalline form of SiO2 is well-established, and 
therefore, OSHA requires workplaces to follow the permissible exposure limits (PEL) set at 
0.05 mg/m3 as a TWA for respirable crystalline SiO2. Inhalation of respirable SiO2 has been 
shown to cause lung inflammation and injury, chronic obstructive pulmonary disorders, 
bronchitis, emphysema, fibrosis, silicotic pneumoconiosis, cancer, heart disease, 
autoimmune disorders and increased risk of infection in humans (Beckett et al., 
1997;Hnizdo, 2003;Kachuri et al., 2014; Liao et al., 2015; Liu et al., 2014;Maciejewska, 
2014;Madl et al., 2008), depending upon duration and level of exposure.
Further, in vivo studies of SiO2 exposure have investigated the mechanisms associated with 
pathologies, such as fibrosis and cancer, including chronic inflammation and the 
upregulation of acute inflammatory mediators like leukotriene B4, upregulation of the NF-jB 
pathway, increased oxidant burden attributable to both the presence of free radicals 
associated with particles and oxidant production by cells in response to SiO2 exposure, 
upregulation of genes associated with mucus production and pulmonary toxicity and 
activation of the inflammasome (Cassel et al., 2008; Kawasaki, 2015; Porter et al., 
2002;Satpathy et al., 2015; Sellamuthu et al., 2013;Vallyathan et al., 1995). In vitro studies 
have shown production of oxidants and inflammatory mediators, activation of cell-signaling 
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pathways associated with cancer, damage to DNA, and increased expression of genes related 
to inflammation, apoptosis, cancer and fibrosis in response to SiO2 exposure (Gwinn et al., 
2009;Ovrevik et al., 2004;Sellamuthu et al., 2011; Shi et al., 1995; Tomaru & Matsuoka, 
2011;Vallyathan et al., 1992), furthering support for mechanisms underlying the pathologies 
observed in animal models of disease related to occupational exposure. SiO2 exposure has 
also been implicated in the alteration to the immunological environment in the respiratory 
tract (Huaux et al., 1998; Langley et al., 2004) and contributions to respiratory susceptibility 
to some infections (Beamer & Holian, 2008;Pasula et al., 2009).
While the pulmonary toxicity to constituents of diesel, and SiO2 are well studied as 
individual exposures, little is known about the effects these particles may have when 
encountered as a mixed exposure. Mining operations including hydraulic fracturing for oil or 
gas, as well as above- and below-ground metal/nonmetal-mining operations, are 
environments where workers may be exposed to constituents of diesel and SiO2 
simultaneously, rendering it paramount to establish whether coexposure to these particles 
will enhance or alter pulmonary toxicity. The current study was designed to investigate the 
hypothesis that combined exposures to these particles would result in amplified injury, 
inflammation and cellular recruitment to the lung in an acute exposure scenario. 
Additionally, our study addressed whether or not cell-mediated clearance of a pathogen 
would be altered by the coexposure. Existing in vivo and in vitro studies documenting the 
toxicity of DPM or SiO2 in vivo often examine doses of these materials representative of 
chronic exposures or doses that exceed typical workplace exposures in single bolus doses 
(Creutzenberg et al., 2008;Ghio et al., 1994;Kajiwara et al., 2007; Ma et al., 2014; Robertson 
et al., 2012; Yang et al., 2001). Therefore, doses for the current study were based on field 
measurements of SiO2 taken during active above-ground mining operations (Esswein et al., 
2013). Values for diesel were derived from both underground mining values (McDonald et 
al., 2002;Pronk et al., 2009) for high-dose values and from existing OELs for elemental 
carbon for the lower dose (SUVA, 2013;OSHwiki Contributors, 2017; TERA, 2014). A 
single acute bolus dose of silica, diesel particulate, or a combination of the particles at 
different doses were administered to Sprague-Dawley rats by intratracheal instillation. Lung 
injury, inflammation and immune responses were evaluated over a three-month time course. 
Additionally, alteration in susceptibility to pulmonary infection following exposure to the 
particles in combination was evaluated to further assess alterations in immune response.
Methods
Particles
Particles in these studies are used as surrogates to represent work site exposures. DPM was 
obtained from the National Institute of Standards and Technology (NIST) as a commercially 
available NIST Standard Reference Material (SRM) 2975 (referred to as DPM in the study). 
SRM 2975 was originally collected from an industrial forklift in the 1990s (Certificate of 
Analysis Standard Reference Material 2013, 2975). The surrogate particle used for SiO2 is 
a-quartz crystalline silica (SIL; MIN-U-SILVR 5, US SILICA; Berkeley Springs, WV).
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Dose determination
Doses were derived from field measurements of particles and applied to the equation below 
(EQ1) to quantify the amount of particle that would deposit in the lung of an average male 
worker doing moderate work (31.3% sitting and 68.8% light exercise) for 12 h per day for a 
period of 14 continuous days using a pulmonary deposition efficacy for each particle derived 
using a software-based algorithm (LUDEP 2.0) that considers particle characteristics 
including mass median aerodynamic diameter and geometric standard deviation, as well as 
shape and density (ICRP, 1994). These doses were then normalized to the surface area of 
both the worker’s and the rat’s lungs to obtain doses for in vivo studies (EQ2). DPM 
estimated as elemental carbon was reported to be variable depending on operations at 
hydraulic fracturing sites; (personal communication with JS related to Esswein et al., 2013; 
unreferenced) however, it was generally below the MSHA recommendation of 160 μg/μ3 
total carbon (120 mg/m3 elemental carbon equivalent), and DPM in underground mining 
operations has been measured in excess of 500 μg/μ3 as elemental carbon as reviewed by 
Pronk et al. (2009). Therefore, in this study, two doses of DPM were evaluated. The low 
dose (7.89 mg per rat) was derived from the OELs for DPM measured as elemental carbon 
of 100 mg/m3 TWA (0.100 mg/L) (EQ3). The high dose of DPM was derived from high 
elemental carbon-level measurements taken during underground mining of 637 μg/μ3(0.637 
μg/L) (EQ4) (McDonald et al., 2002).The SiO2 high dose (233 μg SIL) was derived from the 
highest SiO2 levels measured during hydraulic fracturing site visits (Esswein et al., 2013), 
2.5 μg/m3 (2.5 μg/L) (EQ5). In addition, to assess exposure to equivalent doses of both 
particles at a less toxic dose of SIL, 50 mg of SIL was also evaluated as the low dose of SIL.
= ( field  concentration, μg/1)   ×  (minute ventilation,  1/min)  ×  
(exposure time per day, min/d)  ×  (total fracking days, d)  ×  
(pulmonary deposition efficacy, unitless)
EQ1 - Basic equation for 
standard worker lung deposition:
= (worker′s deposited dose/average male worker lung surface area)  ×  
(average rat lung surface area)
EQ2 - Equation for 
normalization to rat lung surface area:
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Worker lung deposition  =  (0.10 μg=l)  ∗  (20 l/min)  ∗ (720 min/day)  ∗  (14 days)  ∗  (0.10)=2016μg
Dose calculated =(2016 μg/102.2m2) ∗ (0.4m2)
≈ 7.89 μg per rat
EQ3 - Equation for low DPM dose:
Worker lung deposition  =  (0.637 μg=l)  ∗  (20 l/min)  ∗ (720 min/day)  ∗  (14 days) 
∗  (0.10) ≈ 12,842 μg
Dose calculated =(12,842 μg/102.2m2) ∗ (0.4m2) ≈ 50 μg per rat
EQ4 
- Equation for high DPM dose:
Worker lung deposition  =  (2.5 μg=l)  ∗  (20 l/min)  ∗ (720 min/day)  ∗  (14 days)  ∗  (0.118)=59,472 μg per worker
Dose calculated =(59,472 μg/102.2m2) ∗ (0.4m2)
≈ 233 μg per rat
EQ5 - Equation for high SIL Dose:
DPM and SIL preparation and characterization
Particles were prepared in USP-grade phosphate-buffered sterile saline (PBS) without Ca2þ 
or Mg2þ (AMERESCO; Solon, OH) for intratracheal instillation. A sonication process was 
used to disperse agglomerated particles. DPM was prepared as a 2 mg/mL stock solution and 
SIL was prepared as a 10 mg/mL stock solution, vortex mixed for one min, followed by 1 
min of continuous sonication (GE130PB ultrasonic processor; General Electric, Boston, 
MA). Aliquots of stock solution were then further diluted to: 7.89 μg DPM,+50 μg DPM,
+50 μg SIL, 233 μg SIL, 7.89 μg DPM+233 μg SIL, 50 μg DPM+ 50μg SIL or 50 μg DPM
+233 μg SIL in 0.3 mL PBS. Particles were then vortex mixed for an additional 30 s, 
followed by 15 s of sonication prior to intratracheal instillation. Particle preparations were 
dried onto filters and evaluated by field emission scanning electron microscopy (FESEM) to 
determine particle size. Energy- dispersive X-ray (EDX) was performed to determine the 
elemental components of the particles as a measure of particle purity. The DPM was 
comprised primarily of the carbonaceous core, or EC of diesel, with very little detectable 
trace elements including: chromium, copper, iron, nickel, oxygen, silicon and zinc. Due to 
their volatile nature, PAHs cannot be measured using EDX, but the total extractable mass 
including the certified mass fractions of PAHs contained in NIST SRM 2975 is given as 
2.7% of the total sample as described in the certificate of analysis (Certificate of Analysis 
Standard Reference Material 2013, 2975). No trace metals were detected in the SIL sample.
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Animals
Male Sprague-Dawley [Hla:(SD) CVF] (SD) rats from Hilltop Lab Animals (Scottdale, PA), 
weighing approximately 300 g and free of viral pathogens, parasites, mycoplasmas, 
Helicobacter and CAR Bacillus, were used for all studies. Rats were housed in the pathogen 
free, environmentally controlled, Association for Assessment and Accreditation of 
Laboratory Animal Care International (AAALAC)-accredited facility. The rats were housed 
in ventilated polycarbonate cages, two per cage, on Alpha Dri cellulose chips and hardwood 
Beta chips as bedding; they were provided HEPA-filtered air, irradiated Teklad 2918 diet, 
and tap water ad libitum; and were allowed to acclimate for one week before exposure. Rats 
were not restricted from enrichment activity (i.e. chewing/climbing). All animal procedures 
used during the study were reviewed and approved by the Institutional Animal Care and Use 
Committee at the National Institute for Occupational Safety and Health.
Time-course study design: in vivo lung injury, inflammation and disease
On day 0, rats were lightly anesthetized with an intraperito-neal injection of 30–40 mg/kg 
sodium methohexital (Brevital;Eli Lilly, Indianapolis, IN) and intratracheally instilled with 
7.89 μg DPM+50 μg DPM+50 μg SIL, 233 μg SIL, 7.89 μg DPM +233 μg SIL, 50 μg DPM
+233 μg SIL, 50 μg DPM +50 μg SIL or vehicle control (PBS). All particles were delivered 
in 0.3 mL USP-grade PBS. All animals were humanely euthanized at one day, one week, 
one month or three months following particle exposure (n=8/group/ time point) with an 
intraperitoneal injection of 100–300 μg/kg sodium pentobarbital followed by 
exsanguination. Additionally, a two-month postexposure time point was incorporated for 
select dose combinations based on various parameters of toxicity observed in the groups at 
the oneand three-month time points. The trachea was cannulated, bronchoalveolar lavage 
(BAL) was performed on the right lung lobes, and BAL cells (BALC) and fluid (BALF) 
were retained for the analysis of parameters indicative of inflammation, injury, oxidant 
production and immune function. Lung injury and inflammation were evaluated as the 
presence of lactate dehydrogenase (LDH) activity, cytokines and chemokines in BALF. 
BALC were centrifuged onto slides, stained and counted to determine cell phenotype 
differential. BAL lymphocytes were further differentiated by phenotype by flow cytometry. 
Lymphocytes from lymph nodes draining the lung were also differentiated by phenotype. 
Chemiluminescence assays were used to measure oxidant/ free radical production by BAL 
phagocytes to evaluate the inflammatory response. The left lung was excised, pressure-
inflated with 10% neutral-buffered formalin and weighed with water displacement to 
determine fixed lung volume. Histopathological assessment of lung injury, inflammation and 
disease were performed and morphometric analysis of fibrillar collagen content was 
conducted.
Infection study design: pulmonary immune response to infection following particle 
exposure
In this study, rats were exposed to 50 μg DPM,+ 233 μg SIL,50 μg DPM +233 μg SIL 
combined in 0.3 mL PBS or PBS alone (vehicle control) by intratracheal instillation as 
described above. One week following particle exposure, rats were intratracheally instilled 
with 5 105 colony forming units (cfu) of Listeria monocytogenes (strain 10403 S, sero-type 
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1) in 0.5 mL of sterile PBS. Animals were euthanized at 1, 3, 5, 7 and 14 days following 
infection (n=8/dose/time point). BAL was performed on the right lung lobes, and BALC and 
BALF were retained for the analysis of parameters indicative of inflammation, injury and 
immune alteration as described for the time-course study. The left lung was clamped during 
lavage and subsequently excised, homogenized and cultured to evaluate bacterial clearance 
from the lung.
BAL
BAL was performed at each time point after exposure. Following euthanasia as described 
above, the trachea was cannulated, the chest cavity was opened, the left lung bronchus was 
clamped off, and BAL was performed on the right lung lobes. BAL was recovered in two 
fractions. The first fraction of the BAL was obtained by inflating the right lung with 4 mL of 
PBS, massaging for 30 s, withdrawing and repeating the process a second time with the 
same 4 mL of PBS. The second lavage fraction consisted of repeated 6 mL volumes of PBS 
instilled with massaging of the chest cavity, withdrawal and combination until a 30 mL 
volume was recovered. For each animal, both fractions of BAL were centrifuged, the cell 
pellets were combined and resuspended in 1 mL of PBS, and the acellular fluid from the first 
fraction was retained for further analysis described for BALF below.
Analysis of LDH activity
The level of LDH activity in the BALF of all treatment groups was measured at each time 
point after exposure to evaluate cytotoxicity as a measure of lung injury. Measurement of 
LDH activity in the acellular fluid was obtained using a Cobas Mira chemistry analyzer 
(Roche Diagnostic Systems; Montclair, IN). LDH activity was quantified by detection of the 
oxidation of lactate coupled to the reduction of nicotinamide adenine dinucleotide at a 
spectrophotometric setting of 340 nm.
BALF protein analysis
Cytokines and chemokines involved in inflammatory and immune responses were measured 
at each time point after exposure in the BALF of rats treated with PBS, DPM, SIL or 
DPM/SIL combinations, with commercially available enzyme-linked immunosorbent assay 
(ELISA) kits or by multiplex array. The following cytokines and chemokines were 
quantified by ELISA: tumor necrosis factor-α (TNF-α), transforming growth factor-β 
(TGF-β), interleukin (IL)-10, IL-12p70, monocyte chemotactic protein (MCP)-1, 
macrophage inflammatory protein (MIP)-2 (Novex, Life Technologies; Grand Island, NY); 
IL-2, IL-4, IL-6, interferon (IFN)-c (R&D Systems; Minneapolis, MN); and osteopontin 
(OPN, Enzo Life Sciences; Farmingdale, NY). Additionally, two matrix metalloproteinases 
(MMP), MMP-2 and MMP-9, were quantified by ELISA, as well as tissue inhibitor of 
metalloproteinases (TIMP)-1 (R&D Systems) as indices of tissue remodeling due to injury. 
IL-1a, IL-1b, IL-5, IL-13, IL-17 A, IL-18, granulocyte colony-stimulating factor (G-CSF), 
granulocyte and macrophage colony-stimulating factor (GMCSF), eotaxin, leptin, MIP-1a, 
epidermal growth factor (EGF), IFN-c-inducible protein (IP)-10, growth-regulated 
oncogene/keratinocyte chemoattractant (GRO/KC), vascular endothelial growth factor 
(VEGF), fractalkine, lipopolysaccharide (LPS)-induced CXC chemokine (LIX) and 
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regulated on activation, normal T-cell expressed and secreted (RANTES) were assessed by 
multiplex array (Eve Technologies; Alberta, CA).
BALC differentials
Total BALC collected from rats intratracheally instilled with PBS, DPM, SIL or DPM þ SIL 
in combination were counted using a Coulter Multisizer II (Coulter Electronics; Hialeah, 
FL). BALC differentials were performed to determine the total number of alveolar 
macrophages (AMs), neutrophils, lymphocytes and eosinophils. Briefly, 5 104 cells from 
each rat were spun down onto slides with a Cytospin 3 centrifuge (Shandon Life Sciences 
International; Cheshire, England) and labeled with Hema 3®stain (Fisher Scientific; 
Kalamazoo, MI) to differentiate cell types. Two hundred cells per slide were counted, and 
the percentage of AMs, neutrophils, lymphocytes and eosinophils was multiplied by the total 
number of cells to calculate the total number of each cell type.
Chemiluminescence (CL)
To measure the production of reactive oxidant species by BALC, CL was measured 
according to the method of Antonini et al. (Antonini et al., 1994). Luminol (Sigma-Aldrich; 
St. Louis, MO) was used as an amplifier to enhance detection of the light, and 0.2 mg/mL of 
unopsonized zymosan (Sigma-Aldrich) or 3 lM phorbol myristate acetate (PMA; Sigma-
Aldrich) was added to the assay immediately prior to the measurement of CL to activate the 
cells. Because rat neutrophils do not respond to unopsonized zymosan, the zymosan-
stimulated CL produced is from AMs, whereas the soluble stimulant, PMA, activates both 
neutrophils and AMs to generate reactive oxidant species (Castranova et al., 1990). CL was 
quantified using an automated Berthold Autolumat LB 953 luminometer (Wallace, Inc.; 
Gaithersburg, MD). Each sample was measured for 15 min, and the integral of counts per 
minute (cpm) versus time was calculated. The production of CL was calculated as the cpm 
of stimulated cells minus the cpm of the corresponding resting cells, then normalized to the 
total number of BAL AMs for zymosan-stimulated CL and total BALC for PMA-stimulated 
CL.
Phenotypic quantification of BALC and mediastinal lymph node (MLN) cells by flow 
cytometry
Lymphocyte populations in BALC and MLN were differentially assessed for phenotype by 
multicolor flow cytometry analysis. Briefly, cells were obtained by BAL or by 
homogenizing the MLN manually between frosted glass slides followed by filtration. 106 
cells were plated in a 96-well round bottom plate. Cells were washed and blocked for 
nonspecific staining using mouse anti-rat CD32 (FCγRII) antibody (BD Pharmingen™; San 
Diego, CA). Cells were then fluorescently-labeled with one or a combination of the 
following mouse-anti-rat antibodies to determine phenotype: CD3 (T cells), CD3 and CD4 
(T-helper cells), CD3 and CD8a (cytotoxic T cells), CD161a (NKR-P1A; natural killer 
cells), or CD45R (B220; B Cells) (BD Pharmingen™). Cells were then washed and fixed 
with BD Cytofix/Cytoperm™ (BD Pharmingen™) and stored at 4 C until phenotyped using 
a BD™ LSRII flow cytometer and BD FACSDiva™ software v6 (Becton, Dickinson and 
Company; San Jose, CA) (within 24 h). Results were gated and analyzed using ©FlowJo 
Software v10 (FlowJo, LLC; Ashland, OR).
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Histopathology
The left lungs of rats were fixed with 10% neutral buffered formalin by airway pressure 
fixation under 30 cm water pressure to total lung capacity for 15 min. Lung volumes were 
assessed by weight of water displacement. The left lungs were embedded in paraffin, 
sectioned onto slides, and stained with hematoxylin and eosin (H&E) or trichrome. An n = 5 
stained slides for DPM 7.89 mg, DPM 50 mg, DPM 7.89 μg in combination with SIL 233 μg 
and DPM 50 μg in combination with SIL 233 μg were evaluated for each time point of one 
week, one month and three months. Additionally, saline, DPM 50 μg, SIL 233 mg and DPM 
50 μg in combination with SIL 233 μg were also evaluated for the 2-month time point. Study 
blocks were designed with paired controls resulting in n=10 stained slides evaluated for 
saline and SIL 233 μg groups (five from each of the study blocks when combined) for one 
week, one month and three- month time points. Stained slides were analyzed for indications 
of inflammation, injury and fibrosis by a certified veterinary pathologist at Charles River 
Laboratories (Wilmington, MA) who was blinded to the treatment groups. Indices of 
pathology were scored on scale of 0–5, where 0 =no observed effect, 1=minimal response,2 
=mild response, 3=moderate response, 4=marked response and 5 =severe response.
Morphometric analysis of connective tissue thickness
Tissue sections from left lung were deparaffinized and stained with Sirius Red for detection 
of connective tissue, particularly fibrillar collagen. Slides were immersed in 0.1% picrosirius 
solution (100 μg of Sirius Red F3BA in 100 ml of saturated aqueous picric acid) for 2 h 
followed by washing for 1 min in 0.01 N HCl. Slides were then counterstained with 
hematoxylin for 2 min, dehydrated and mounted with a coverslip for imaging. Quantitative 
morphometric methods were used to measure the average thickness of Sirius Red-positive 
connective tissue in the alveolar regions. Volume (% of the alveolar wall) and thickness were 
measured by standard morphometric analyzes that consisted of basic point and intercept 
counting (Mercer et al., 1994; Underwood, 1970). Grid pattern, X and Y boundaries and 
number of intersections were determined as previously described (Roberts et al., 2012). 
Volume was determined by counting the number of points over the Sirius Red-positive 
connective tissues in the alveolar regions. Surface density of the alveolar wall was 
determined from intercepts between a line overlay and the alveolar wall. To limit the 
measurements to alveolar parenchyma, areas containing airways or blood vessels 25 lm in 
diameter were excluded from the analysis. Average thickness of the Sirius Red-positive 
connective tissue of the alveolar wall was computed as from two times the ratio of volume 
density of point to the surface density of the alveolar wall.
Bacterial clearance from the lung
To measure the clearance of bacteria from the lung, left lungs were excised and placed in 10 
mL of sterile deionized water. Lungs were homogenized using a PolytronV R PT-2100 
homogenizer with PT-DA 2112/EC aggregate attachment (Kinematica; Bohemia, NY). 
Homogenates were diluted and cultured on prepared Brain Heart Infusion Agar plates 
(Becton, Dickinson and Company). Cultures were incubated at 37°C for 24h. Cfu were 
counted and multiplied according to culture dilution factors.
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Statistical analyses
Results for all BAL parameters, cellular phenotype, morphometry and bacterial clearance 
were expressed as mean fold change from control calculated as X control X  and a one way 
analysis of variance (ANOVA) was performed between all treatments groups at each time 
point. Significant differences among groups were determined using the Student–Newman–
Keuls post hoc test. Data were analyzed using SigmaPlot for Windows Version 12.5 (Systat 
Software, Inc.;Ekrath, Germany). For all analyses, significance was set at p < .05. Because 
data from histopathology studies are inherently categorical, nonparametric analysis of 
variance was assessed using SAS/STAT software, Version 9.1, of the SAS System for 
Windows statistical programs (SAS Institute, Inc.; Cary, NC). In this instance, groups were 
compared using the Wilcoxon rank sum test.
Results
Particle characterization
One ml aliquots of 7.89 μg dose DPM,+50 μg dose DPM+233 mg dose of SIL, as well as 
7.89 mg and 50 μg DPM in combination with SIL 233 μg (DS) in PBS solution, were dried 
on carbon filters and examined using FESEM in order to characterize size of the primary 
particles and their degree of agglomeration. In solution, DPM was found to agglomerate to a 
size of approximately 2 mm in diameter. The primary particle size was found to be smaller 
in size, 200 nm. The primary particles of SIL were approximately 2 mm in size and were 
evenly distributed in suspension (Figure 1(A,B)). The association between DPM and SIL in 
solution was minimal. EDX was used to evaluate the elemental components of each particle. 
DPM was found to be composed of primarily carbon, reflecting the carbonaceous core of the 
DPM, with very little detectable trace elements including: chromium, copper, iron, nickel, 
oxygen, silicon and zinc adsorbed to it (Figure 1(C)). The EDX spectrum of the SIL sample 
is depicted in Figure 1(D).
Time-course study
Lung injury was evaluated by examining LDH in the BALF collected from rats at one day, 
one week, one month, two months and three months postexposure to particles. LDH activity 
was significantly increased in all groups that contained the high dose of SIL (233 mg) and 
the high dose of SIL alone at all time points following exposure when compared to control 
(Figure 2). At early time points, the increase in groups that were coexposed to SIL and DPM 
was primarily driven by SIL particles. However, by 3 months, coexposure to the high doses 
of DPM and SIL (DS 50/233) resulted in an increase when compared to all other groups. 
There were no significant increases in LDH activity in groups exposed to DPM alone at 
either dose, SIL 50 alone, or DS 50/50.
Protein mediators were evaluated in BALF as a measure of inflammation and immune 
response (Table 1). The low dose of DPM (DPM 7.89) and the low dose of silica (SIL50) did 
not cause any significant changes in BALF protein when compared to control with the 
exception of DPM 7.89, whereby IL-10 was significantly elevated (data not shown). The 
high dose of SIL caused increases in several proteins associated with inflammation; MCP-1, 
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MIP-1a, RANTES, GRO/KC, MIP-2, IP-10, TNF-a and IFN-c compared with the control 
and groups exposed to DPM only. SIL 233 alone and the DS 50/233 groups caused a 
decrease in the anti-inflammatory protein IL-10 from one week to 2 months postexposure 
compared with control and DPM-exposed groups. SIL 233 alone and the DS 50/233 groups 
also caused a significant increase in MMP-9, a protein associated with tissue remodeling 
which has implications in the development of fibrotic changes in the lung, at all time points 
following exposure. Additionally, SIL high-dose exposure increased MMP-2 and OPN, 
additional proteins associated with tissue remodeling, wound healing and fibrosis at one 
month post exposure and at all time points thereafter for OPN. Finally, the SIL high dose 
alone or in combination with the DPM high dose caused an increase in IL-18, a protein 
associated with upregulation of the NLRP3/NALP3 inflammasome, at later time points. 
DPM 50 alone did not illicit an increase in pro-inflammatory cytokines. However, the high 
dose of DPM did cause a decrease in IL-2 and IFN-c proteins associated with the effector 
properties of Th1cells, when compared with controls. The decrease in IL-2 was also present 
in the high-dose coexposure group (DS 50/ 233). Similarly, DPM in combination with SIL 
exhibited independent action on the expression of some cytokines like, MIP-a, GRO/KC, 
MIP-2, MMP-2 and MMP-9 at some time points (Table 1), suggesting that DPM in a 
coexposure may have the capability to reduce the effects observed with SIL alone. These 
observations may indicate altered macrophage and lymphocyte activity in response to 
treatment with DPM. There were no significant changes in the following cytokines in any 
group: EGF, eotaxin, fractalkine, G-CSF, GM-CSF, IL-1a, IL-1b, IL-4, IL-5, IL-6, IL-12p70, 
IL-13, IL-17 A, leptin, LIX, TGF-b, TIMP-1 and VEGF (data not shown).
Cell differentials were performed on BALC to further assess inflammation (Figure 3(A,B)). 
DPM alone at either dose did not cause an increase in the influx of AMs (Figure 3(A)) or 
neutrophils (Figure 3(B)). AM influx was increased in all groups that contained SIL 233 
beginning at one-week postexposure. Neutrophil influx significantly increased as early as 
one-day postexposure in all groups containing SIL 233 (Figure 3(B)) and persisted 
throughout the time course. Exposure to SIL 50 μg showed a trend toward an increase in 
neutrophils up to one month following exposure with resolution of response over time. At 
one month, exposure to DS 50/233 caused a significant increase in neutrophils when 
compared to all groups. The DS50/50 group followed a similar pattern as SIL 50 alone. 
BALC activation was also evaluated as oxidant production ex vivo (Figure 3(C,D)). DPM 
only doses used in this study did not cause an increase in oxidant production by AMs and 
neutrophils as measured by CL. Oxidant production in the SIL 233 group significantly 
increased for both total phagocytes at one day and at three months postexposure (Figure 
3(C)) and oxidant production by macrophages followed a similar pattern (Figure 3(D)). 
Interestingly, exposure to the higher dose of DPM combined with the high dose of SIL 
resulted in significantly increased oxidant production over exposure to the high dose of SIL 
alone at one week, one month and two months postexposure, suggesting a higher oxidant 
burden in the lung of rats in the high-dose coexposure group at these times.
BAL and MLN lymphocytes were phenotyped by flow cytometry. In addition to phagocytic 
influx described in Figure 3, exposure to SIL at the high dose alone or in combinations with 
DPM 50 caused significantly increased lymphocyte influx into the lung as early as one day 
following exposure (Table 2) and proliferation in the MLN as early as one-week 
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postexposure (Table 3). This effect was attributed primarily to CD4+ and CD8+ T-cell 
population subsets. Exposure to DPM+50 alone did not cause a significant increase in 
lymphocyte populations in BAL or MLN. Additionally, it was noted that for the coexposed 
group, DPM exhibited independent action reducing the influx of the CD8+subset of cells 
into the lung observed with the SIL only exposed group at one month and total T cells, 
which was mostly attributed to reduced influx of the CD4+T cell subset, at three months 
following exposure.
H&E and trichrome-stained tissue sections were evaluated by a board certified veterinarian 
pathologist (Table 4). DPM alone at either dose did not cause pathological changes in the 
lung. Influx of AMs, as a measure of inflammation, was significantly elevated in the SIL 233 
group alone at all time points following exposure and when combined with DPM at one 
month following exposure. Alveolar epithelial hyperplasia (AEH) was also observed at all 
points following exposure in DS 50/233-exposed groups. At one month following exposure 
to particles, minimal to mild septal fibrosis was observed in groups exposed to SIL 233. 
Interestingly, incidence of septal fibrosis was significantly increased by coexposure to the 
high doses of DPM and SIL at one month. By three months after exposure, occurrence of 
septal fibrosis was equivalent in both SIL 233 only and coexposed groups. Groups exposed 
to SIL in combination with high-dose DPM scored significantly higher for particles in tissue 
versus DPM alone as indicated by the presence of brown granules accumulated in 
macrophages, which corresponds to an observation of increased coloration in lymph nodes 
as well. Furthermore, mild hyperplasia of the bronchiolar/alveolar epithelium was observed 
near the terminal bronchioles at two months following exposure and was found to be 
associated with the presence of macrophages loaded with high particle content, suggesting a 
correlation between tissue damage and the presence of particles (data not shown). SIL 50 
and DS 50/50 were not evaluated as BAL parameters of injury and inflammation were not 
increased in the DS50/50 coexposure group. Overall, most histopathological changes were 
attributable to exposure to 233 μg of SIL; however, the presence of DPM often increased the 
severity and/or incidence of these changes in the coexposure groups.
To further quantify observations of fibrosis, alveolar expansion, alveolar septal wall 
thickness and thickness of fibrillar collagen were measured by morphometry to further 
assess the fibrotic response to exposure. Alveolar expansion was measured as a ratio of the 
total airspace volume to volume versus the surface to volume of the epithelial surface 
intercepts or thickness of airspace between alveolar tissues. Alveolar septal wall thickness 
was measured as a ratio of the total volume to volume of alveolar tissue versus the surface to 
volume of epithelial surface intercepts. No significant differences were observed between 
the treatment groups. Additionally, fibrillar collagen thickness was measured as the ratio of 
total collagen volume to volume versus total epithelial surface intercepts surface to volume. 
This measurement is indicative of fibrotic development in lung tissue. Although not 
statistically significant, there was a trend for increased fibrillar collagen volume in SIL 233-
exposed groups and this trend was further increased for coexposed groups at the latest time 
points measured (data not shown).
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Infection study
In order to investigate the effects of particle exposure on respiratory susceptibility to a 
bacterial pathogen, an infectivity study was conducted to assess the clearance of L. 
monocytogenes from the lung over a 14-day time course one week following exposure to 
particles. Despite lung inflammation and phagocytic cell activity observed in the absence of 
infection in coexposed groups (Figure 3), overall clearance of the pathogen was not 
significantly altered between these treatment groups (Figure 4(A)). The data suggest that, for 
the doses of DPM used in this study, which were not found to induce toxicity by themselves, 
combination with moderately toxic doses of SIL did not alter susceptibility to an infection 
with Listeria monocytogenes. Influx of cells into the lungs was significantly increased for 
SIL 233–exposed groups at day-1 postinfection (Figure 4). This influx appeared to be 
comprised mostly of neutrophils (Figure 4(D)) and lymphocytes. By day-3 postinfection, the 
influx of cells in SIL 233–exposed groups was resolved. Finally, cells from the BAL and 
MLN were phenotyped as in the time-course study to evaluate lymphocyte populations. For 
the SIL-233-exposed group, the influx of lymphocytes into the BAL at day-1 post-infection 
was significantly greater when compared with the control group and again on day 14. DPM 
exposure caused no significant alterations in lymphocyte influx into the lung, while 
combined exposure to particles caused significant increases in total lymphocyte influx at day 
14 compared with control and DPM exposed groups comprised mostly of CD4+ cells (Table 
5). In the MLN, the SIL 233–exposed group had significantly increased lymphocytes, 
specifically CD4+ T Cells, compared with control and overall T-cell populations were 
significantly increased when compared to control and DPM 50 at day-1 postinfection. 
SIL-233 exposure also increased total lymphocytes in the MLN compared with all other 
groups at day-3 postinfection. DPM exposure caused significant decreases compared with 
SIL-exposed group for total T cells at day-3 postinfection and caused significant decreases 
in the CD8+subset of T cells compared with SIL-233 and control groups for the same time 
point. Finally, combined exposure caused increased lymphocytes at day 1 for total cells and 
total T cells compared with control group and compared with DPM and control for the 
CD4+T-cell subset (Table 6).
Discussion
The current study was conducted in order to address a knowledge gap with relation to 
coexposures representative of those which may occur in mining industry occupations, 
including hydraulic fracturing. It is important to note that the DPM used in this study was 
extracted from DE collected from an industrial forklift in the 1990s, which qualifies it as 
“transitional” in nature (collected between 1988 and 2006). Transitional DE samples vary 
from “traditional” DE or “TDE” (collected prior to 1988) and New Technology DE or 
“NTDE” (collected post-2006) in chemical and physical properties. TDE is considered to be 
more hazardous in nature due to having a larger amount of particulate matter, carbon 
monoxide and hydrocarbon emissions while NTDE has significantly lower TDE-related 
emissions (Hesterberg et al., 2009); however, very little information is available on health 
outcomes related to NTDE exposure. Additionally, the current study examined DPM only 
and not total DE, which contains higher levels of metals and hydrocarbons, which in turn 
may lead to greater toxicity following exposure to DE. The silica used in this study was also 
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a surrogate for occupational exposures that occur in mining operations and oil and gas 
extraction. It is not a freshly fractured form of crystalline silica, which has been shown to be 
higher in toxicity than aged silica (Vallyathan et al., 1995), and although sand used at 
hydraulic fracturing sites contains respirable silica, composition of the sand may vary from 
site to site (Beckwith, 2011; Brown, 2012).
While most parameters of toxicity evaluated could be attributed to the more reactive and 
toxic crystalline silica particles, DPM, at doses that represent different durations of exposure 
based on field measures taken at mining sites and OELs, did exacerbate the effects of silica 
in the acute exposure model examined, particularly between 1 week and 1 month post-
exposure. This exacerbation was observed for the parameters of pulmonary inflammation, 
quantified by the influx of neutrophils into the lung (Figure 3(B)) as well as by the oxidant 
production by phagocytes (Figure 3(C,D)) at time points up to one month for inflammation 
and up to three months for oxidant production. Furthermore, assessment of pathology in the 
lung tissue suggested that DPM may be contributing to the mild fibrotic response induced by 
silica in the lung, whereby there was an increased incidence of mild fibrosis at one-month 
postexposure in the animals that were exposed to the combination of the high doses of 
particulate. Additionally, while silica contributed to an increase in lymphocyte- and 
immune-related cytokines in the lungs (Tables 1–3), DPM reduced the expression of many 
proteins including: MIP-1a, GRO/KC, MIP-2, IL-2, IFN-c, MMP-2 and MMP-9, in the 
BALF when in combination with silica, especially at early time points. DPM may exhibit 
independent action on macrophage activity, as well as lymphocyte influx and proliferation 
thus attenuating the effects induced on these cell types by silica alone (Tables 1–3). 
Immunological alterations were further examined by evaluating susceptibility to an infection 
following particulate exposure. While some alterations in immune cellular influx were 
observed in silica-exposed groups (Tables 5 and 6), the exposures did not alter the bacterial 
clearance rate or resolution of infection (Figure 4).
The toxicological properties of crystalline silica are well established. Silica is known to 
cause fibrotic changes in the lung following both acute exposures to bolus doses of particles 
and chronic lower dose exposure to particles (Castranova & Vallyathan, 2000). The 
mechanism directing the toxicity of silica particles in the lung still remains ambiguous but is 
thought to stem from multiple attributes relating to the crystalline structure of silica and its 
reactivity based on either surface charge or silicon-containing groups present on the surface 
of silica due to disruptions made to its structure during crushing, grinding and drilling 
(Castranova & Vallyathan, 2000). In conjunction with this, reactive oxygen/nitrogen species 
(ROS/RNS) associated with the particles themselves or as products of the respiratory burst 
following activation of phagocytes have been shown to drive a prolonged state of 
inflammation in the lungs (Blackford et al., 1994; Costa et al., 1991; Vallyathan et al., 1992, 
1995). Studies investigating pulmonary toxicity of diesel demonstrate DPM-induced 
inflammation and oxidative stress as well (Bayram et al., 1998; Kim et al., 2016; Ohtoshi et 
al., 1998; Sagai et al., 1993, 1996); however, unlike silica, DPM exposure does not have the 
same propensity to cause fibrosis. Instead, chronic exposures to DE/DPM have been shown 
to cause disease outcomes including chronic obstructive pulmonary disorder, emphysema 
and cancer (Garshick et al., 2004; Hart et al., 2012; Kachuri et al., 2016; Wong et al., 1985).
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In regards to potential mechanisms in the development of fibrosis, crystalline silica particles 
have been shown to either bind to scavenger receptors on alternatively activated 
macrophages (M2) followed by uptake into the cell in a phagosome, or the particles are 
phagocytosed by a classically activated macrophage (M1) in the interstitium once the M2 
macrophages become overloaded (Kawasaki 2015). M2s are phenotypically distinct from 
M1s, being activated primarily by IL-4 and IL-13 rather than IFN-c and are typically less 
involved in killing of microbes/clearance and more associated with functions of wound 
healing and collagen development (Mosser & Zhang, 2008). As reviewed by Kawasaki and 
demonstrated in original work by Joshi et al. (Fubini & Hubbard, 2003; Joshi et al., 2015; 
Kawasaki, 2015), the uptake of these particles triggers a signaling cascade within 
macrophages which leads to: the release of recruitment factors for additional inflammatory/
immune cells, stimulation of the autocrine and paracrine production of fibrogenic mediators, 
and, most notably, either the successful clearance of particles from the lung to either the GI 
tract or lymphatics or the eventual phagolysosomal destruction and death of the cell that 
engulfed the particles. Directly following the death of a macrophage containing silica, the 
particles are engulfed by another nearby phagocyte. This repeated cycle of uptake, release 
and reuptake continues in the lung until a point which cellular signals lead to the formation 
of a granuloma to sequester particles in an effort to reduce damage to the surrounding tissue 
(Dauber et al., 1980; Deshazo, 1982; Heppleston, 1982). It is hypothesized that M1-type 
macrophages may initiate this process (Kawasaki, 2015), but other cell types, including 
lymphocytes, epitheliod monocytes and macrophages and giant cells, are involved as well 
(Co et al., 2004; Langley et al., 2004; Prieditis & Adamson, 1996).
In relation to the fibrotic paradigm discussed above, this study showed that there were 
significant increases in neutro-phil and lymphocyte recruitment in the high-dose coexposed 
group when compared to the silica-exposed group, along with significant increases in 
cytotoxicity in the lung measured as LDH in BALF, and this was accompanied by the 
increase in incidence of mild fibrosis at one-month postexposure in the high-dose 
coexposure group. While the interaction of silica with receptors was not investigated in the 
present study, downstream mediators of these interactions were increased in the BALF. 
Increases in chemotactic/ recruitment proteins associated with inflammation (MCP-1, 
MIP-1a, RANTES, GRO/KC, MIP-2, IP-10 and TNF-a) were significantly increased in the 
groups containing the high dose of silica, and the increases tended to progress throughout 
the time course (Table 1), whereas the anti-inflammatory protein, IL-10, was significantly 
decreased in silica-exposed groups throughout the time course. Additionally, OPN, MMP-2 
and MMP-9, proteins involved in tissue remodeling, were also significantly increased in 
silica-exposed groups, particularly later in the time course. Though differences between the 
high-dose coexposed group and high-dose silica-exposed group separately were not 
statistically significant for this parameter, there was approximately a 30% increase in 
MMP-9 expression, at the latest time point, suggesting a trend for increased tissue 
remodeling in the coexposed group over that of silica alone.
In addition to the pro-inflammatory responses discussed above, a significant increase in 
IL-18 at later time points following silica exposure was measured for both the high dose 
coexposed and high-dose silica only groups. The NLRP3 inflammasome is an immune 
system mediator that detects danger signals produced by damaged cells. The inflamma-some 
Farris et al. Page 16
Inhal Toxicol. Author manuscript; available in PMC 2019 June 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
is also activated by stimulation with foreign bioreactive particles like multiwalled carbon 
nanotubes, which cause production of oxidants by phagocytic cells leading to upregulation 
of NLRP3 complex formation, resulting in the cleavage of IL-18 and IL-1b and prolonged 
inflammation and fibrotic development in the lung (Gasse et al., 2009; Lee et al., 2016; 
Riteau et al., 2010; Sager et al., 2014; Sun et al., 2015). Crystalline silica exposure has also 
been shown to upregulate the activity of the NALP3/NLRP3 inflammasome following 
binding to scavenger receptors on macrophages both in vitro (Cassel et al., 2008; Dostert et 
al., 2008; Peeters et al., 2014) and in vivo (Peeters et al., 2014) leading to the cleavage of 
IL-1b and IL-18 to their active forms by caspases leading to apoptosis or pyroptosis in cells 
(Cassel et al., 2008; Iyer et al., 1996). While we did not observe an increase in IL-1b, we did 
observe an increase in IL-18 for both the SIL 233 and high-dose coexposed groups. At time 
points as early as one week following exposure, IL-18 was significantly increased in both 
groups compared with DPM 50, but by 3 months, both groups were significantly greater 
than both DPM 50 and control (Table 1). Therefore, inflammasome activation may also be 
occurring as an early response in the development of fibrosis.
In addition to the pro-inflammatory properties of both DPM and crystalline silica, both 
particles have been shown to alter mechanisms of pulmonary immunity, although the effects 
following exposure to these particles differ in this regard. Silica has been shown to cause 
hyper-activation and hyper-responsiveness of both macrophages (Castranova et al., 1985; 
Migliaccio et al., 2005) and T cells (Langley et al., 2004; Rocha-Parise et al., 2014). This 
was also demonstrated in the current study in the group exposed only to the high dose of 
silica individually. Conversely, DPM has been shown to suppress activation and effector 
functions of macrophages and T cells, and this suppression has been associated with 
increased susceptibility to infection and reduced pulmonary clearance of pathogens 
(Burchiel et al., 2004; Castranova et al., 1985; Mundandhara et al., 2006; Pierdominici et al., 
2014; Yang et al., 1999, 2001; Yin et al. 2002, 2007). Because both DPM and silica 
exposure have been shown to increase lung inflammation and phagocytic recruitment in 
acute exposures but lead to decreased clearance following chronic exposure, it was of 
interest to determine whether the capacity for the clearance of a pathogen in an acute model 
of exposure to the particles in combination would be altered. In the present study, a 
difference in bacterial clearance from the lungs was not observed following exposure to 
DPM, silica, or the DPM and silica coexpo-sure (Figure 4(A)); this may reflect the lower 
doses delivered here when compared to previous studies (Castranova et al., 2001; Cowie, 
1994; Pasula et al., 2009; Sherson & Lander, 1990; Yang et al., 2001; Yin et al., 2002). 
Other differences among studies include the degree to which DPM or SIL were freshly 
collected, thus making them less reactive than particles that workers in the field may be 
exposed to (Castranova & Vallyathan, 2000; Dalal et al., 1990; Shoemaker et al., 1995), and 
the engine source of the DPM which would determine the elemental constituents. In 
addition, the timing of the infection may influence clearance of the infection following 
exposure. In studies in which a pathogenic response was examined more acutely (within 3 
days of particle exposure), DPM exposure reduced clearance of the infection (Castranova et 
al., 2001; Yang et al., 2001; Yin et al., 2002). In response to silica exposure, clearance of 
bacteria has been shown to be critically dependent upon whether exposure is acute (Antonini 
et al., 2000), resulting in increased clearance of infection due to enhanced inflammatory and 
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essentially a “primed” macrophage response for effective uptake and clearance of the 
bacteria, or chronic, resulting in decreased clearance (Cowie, 1994; Pasula et al., 2009; 
Sherson & Lander, 1990) suggesting the degree of lung injury present would alter 
susceptibility to infection. Further investigation is needed to determine the effects that 
particles might have on clearance and susceptibility to infections experienced more 
subsequently to particle exposure. Given that we observed development of fibrosis at later 
time points, administering bacteria later in the time course, such as at 1, 2 or 3 months may 
result in more similar effects to what has been observed in chronic silica exposures 
previously (Cowie, 1994; Pasula et al., 2009; Sherson & Lander, 1990).
Conclusion
The data taken together show that DPM exposure at doses that do not elicit pulmonary 
toxicity has the capacity to significantly alter silica-induced pulmonary effects, primarily 
inflammation, oxidant production and rate of onset of fibrotic changes in the lung, as well as 
exhibit independent action which mediates some immune cell activity when the exposure 
occurs simultaneously as a mixture. The current study does not delineate the specific 
interactions between the two particulates in the lung following exposure and leading to the 
observed effects. One possibility is that presence of and/or injury induced by crystalline 
silica alters the clearance rate of the DPM particles from the lung, which in turn results in a 
longer persistence of DPM in the lung in conjunction with silica. DPM alone may be cleared 
at a greater rate resulting in the lack of observed toxicity following the individual exposures 
in this study. This hypothesis is supported by the evidence from the histopathology analysis 
in the observance of brown granules (DPM) in the lungs of only the coexposed group and by 
the presence of DPM particles in the lymph nodes of only the co-exposed group at the later 
time points and not the DPM-only exposure. Another possibility for the observed effects 
may be related to the particle load as a result of DPM and crystalline silica delivered to the 
lung simultaneously. Although the delivered doses by intratracheal instillation in these 
studies are lower than many previous studies (Antonini et al., 2000; Castranova et al., 2001; 
Pasula et al., 2009; Yang et al., 2001), the coexposed group received a total particle load of 
283 mg compared to the individual silica load of 233 mg and the DPM load of 50 mg, which 
is an increase in load of 18%. It is also important to note that though the doses are reflective 
of occupational settings and exposure over a period of time, intratracheal instillation does 
result in delivery of a bolus dose of particles rather than delivery of particles by inhalation at 
lower doses over time, which may affect the acute responses at the early time points 
postexposure instilling the particles ensure delivery of the entire dose to the lower 
respiratory tract of the lung, but overall is less physiological in nature than inhalation. 
Studies are underway to address doses administered as an intratracheal bolus and the effects 
of load and clearance in relationship to the combined exposure of DPM and silica.
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Figure 1. 
FESEM images of particles. (A) 233 mg SIL and 7.89 mg DPM in combination prepared in 
PBS solution, diluted 1:10 in PBS, then dried onto a filter under 20,000x magnification 
(scale bar=2 mm with 10 segments of 0.2 mm each) (B) 233 mg SIL and 50 mg DPM 
prepared in PBS solution, diluted 1:10 in PBS, then dried onto a filter in PBS solution under 
20,000x magnification (scale bar =2 mm with 10 segments of 0.2 mm each). White arrows 
indicate SIL and black arrows indicate DPM. (C) EDX of DPM particles pictured in the 
FESEM above at 20 keV. Labeled spectral peaks for elements primarily present in the 
samples. All peaks besides carbon are elements commonly found in DPM but present only 
in trace amounts in this sample (chromium, copper, iron, nickel, oxygen, silicon and zinc). 
(D) EDX of SIL particles pictured in FESEM above at 20 keV.
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Figure 2. 
LDH activity in BALF after exposure to DPM, SIL or a combination of DPM and SIL (DS) 
at indicated doses (μg). Data are shown as mean fold change over control (y= 0). Neither 
DPM +7.89 mg nor DS 7.89/233 μg were evaluated at 2 months.aDifferent from control, 
DPM 7.89 μg, DPM +50 mg, SIL 50 μg, DS 50/50 μg groups;bdifferent from all other 
groups;cdifferent from control, DPM+50 μg, SIL 50 μg and DS 50/50 μg groups. Statistical 
significance is p=05.
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Figure 3. 
Total AMs (A) and neutrophils (B) in the BALF following exposure to DPM,SIL or DS at 
doses indicated. Production of oxidants by total phagocytes stimulated with PMA (C) or by 
AMs only stimulated by zymosan (D) measured by chemiluminescence following exposure 
to DPM, SIL or DS at doses indicated. DPM7.89 mg was not evaluated at 2 months. All data 
are shown as a mean fold change over control (y = 0).aDifferent from control, DPM 7.89 μg, 
DPM+50 μg, SIL 50 μg, DS 50/50 μg groups;bdifferent from all other groups;cdifferent from 
control, DPM+50 μg, SIL 50 μg, and DS 50/50 μg groups;ddifferent from control and DPM
+50 +μg only;edifferent from control, DPM +50 μg, and SIL 50 μg groups;fdifferent from 
control, DPM +7.89 μg, DPM 50 μg, SIL 50 μg, SIL 233, and DS 50/50 μg;gdifferent from 
control, DPM 7.89 μg, DPM+50 μg and SIL 50 μg groups. Statistical significance measured 
as p≥05.
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Figure 4. 
(A) Bacterial burden in the left lung over the time course. Data are shown on a log10 scale. 
Total cells (B), total AMs (C) and total neutrophils (D) recovered by lavage following 
exposure to DPM, SIL or DS at doses indicated. (B–D) Data are shown as a mean fold 
change over control (y=0). _Different from control and DPM 50 μg; @different from 
control. Statistical significance is p=05.
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po
su
re
D
PM
 5
0
0.
35
 ±
 0
.1
4
0.
39
 ±
 0
.1
7
0.
44
 ±
 0
.1
9
0.
36
 ±
 0
.1
7
0.
29
 ±
 0
.1
3
SI
L 
23
3
1.
24
 ±
 0
.1
0*
1.
50
 ±
 0
.1
1*
1.
44
 ±
 0
.1
2*
1.
73
 ±
 0
.2
4*
0.
99
 ±
 0
.1
1*
D
S 
50
/2
33
1.
37
 ±
 0
.2
3*
1.
56
 ±
 0
.2
3*
1.
53
 ±
 0
.2
3*
1.
58
 ±
 0
.2
8*
0.
99
 ±
 0
.2
1*
M
on
th
-1
 p
os
te
x
po
su
re
D
PM
 5
0
−
0.
05
 ±
 0
.0
8
0.
01
 ±
 0
.0
8
0.
04
 ±
 0
.0
9
−
0.
04
 ±
 0
.0
9
−
0.
10
 ±
 0
.0
9
SI
L 
23
3
0.
70
 ±
 0
.2
4*
1.
00
 ±
0.
31
*
0.
94
 ±
 0
.3
1*
1.
19
 ±
 0
.3
4*
0.
53
 ±
 0
.1
9*
D
S 
50
/2
33
0.
87
 ±
 0
.1
5*
1.
36
 ±
 0
.2
5*
1.
17
 ±
 0
.2
6*
1.
71
 ±
0.
32
*
0.
60
 ±
 0
.1
1*
M
on
th
-2
 p
os
te
x
po
su
re
D
PM
 5
0
0.
02
 ±
 0
.1
2
0.
10
 ±
 0
.1
3
0.
18
 ±
 0
.1
2
0.
00
3 
± 
0.
15
0.
03
 ±
 0
.1
2
SI
L 
23
3
2.
91
 ±
 0
.4
3*
3.
79
 ±
 0
.5
9*
3.
76
 ±
 0
.6
6*
4.
07
 ±
 0
.5
8*
2.
98
 ±
 0
.4
3*
D
S 
50
/2
33
3.
23
 ±
 0
.2
6*
3.
89
 ±
 0
.3
3*
3.
66
 ±
 0
.3
3*
4.
62
 ±
 0
.4
8*
3.
52
 ±
 0
.4
1*
M
on
th
-3
 p
os
te
x
po
su
re
D
PM
 5
0
0.
11
 ±
 0
.0
4
0.
02
 ±
 0
.0
6
0.
09
 ±
 0
.0
7
−
0.
14
 ±
 0
.1
2
0.
15
 ±
 0
.0
5
SI
L 
23
3
4.
98
 ±
 1
.1
7*
6.
02
 ±
 1
.3
8*
5.
17
 ±
 1
.1
1*
7.
97
 ±
 1
.8
9*
4.
46
 ±
 1
.1
5*
D
S 
50
/2
33
4.
74
 ±
 0
.7
0*
5.
92
 ±
 0
.9
0*
5.
30
 ±
 0
.7
1*
6.
84
 ±
 1
.4
1*
4.
34
 ±
 0
.7
1*
A
ll 
da
ta
 a
re
 sh
ow
n
 a
s 
m
ea
n
 fo
ld
 c
ha
ng
e 
ov
er
 c
o
n
tr
ol
 ±
 st
an
da
rd
 e
rro
r.
*
D
iff
er
en
t f
ro
m
 c
on
tro
l a
nd
 D
PM
+5
0 
μg
.
St
at
ist
ic
al
 si
gn
ifi
ca
nc
e 
is 
p 
≤.
05
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Ta
bl
e 
4.
Se
v
er
ity
 a
nd
 in
ci
de
nc
e 
sc
or
es
 fo
r l
ef
t l
un
g 
lo
be
s o
f S
pr
ag
ue
-D
aw
le
y 
ra
ts 
ex
po
se
d 
to
 D
PM
, S
IL
 o
r D
PM
 a
nd
 S
IL
 c
om
bi
ne
d 
in
 v
ar
yi
ng
 d
os
es
.
Ex
po
su
re
 g
ro
u
p 
(μ
g)
Ti
m
e 
po
st
ex
po
su
re
A
M
A
EH
BH
LN
I
BG
F
Co
nt
ro
l
1 
w
ee
k
0.
2 
(2/
10
) D
0
0.
1 
(1/
10
) M
0
0
0
D
PM
 7
.8
9
1 
w
ee
k
0
0
0
0
0
0
D
PM
 5
0
1 
w
ee
k
0.
2 
(1/
5) 
D
0
0
0
0
0
SI
L 
23
3
1 
w
ee
k
1.
3 
(10
/10
) D
f
0
0
0.
1 
(1/
10
) M
0
0
D
S 
7.
89
/2
33
1 
w
ee
k
1 
(5/
5) 
D
0
0.
2 
(1/
5) 
M
0
0
0
D
S 
50
/2
33
1 
w
ee
k
2 
(5/
5) 
Dd
,
*
0.
4 
(2/
5) 
M
e
0
0
0.
4 
(2/
5) 
M
e
0
Co
nt
ro
l
1 
m
on
th
0.
3 
(3/
10
) D
0
0
0
0
0
D
PM
 7
.8
9
1 
m
on
th
1 
(5/
5) 
D
0
0
0
0
0
D
PM
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0
1 
m
on
th
0
0
0
0
0
0
SI
L 
23
3
1 
m
on
th
1.
7 
(10
/10
) D
b , *
0.
3 
(3/
10
) M
0
0
0
0.
2 
(2/
10
) M
D
S 
7.
89
/2
33
1 
m
on
th
1.
8 
(5/
5) 
Db
0.
4 
(2/
5) 
M
0
0
0
0.
2 
(1/
5) 
M
D
S 
50
/2
33
1 
m
on
th
1.
8 
(5/
5) 
Db
1 
(5/
5) 
M
d , *
0
0
0.
8 
(4/
5) 
M
a ,
*
0.
8 
(4/
5) 
M
d , *
*
Co
nt
ro
l
3 
m
on
th
s
0.
5 
(5/
10
) D
0
0
0
0
0
D
PM
 7
.8
9
3 
m
on
th
s
0.
6 
(3/
5) 
D
0
0
0
0
0
D
PM
 5
0
3 
m
on
th
s
0.
8 
(4/
5) 
D
0
0
0
0
0
SI
L 
23
3
3 
m
on
th
s
1.
8 
(10
/10
) D
f , *
*
1.
1 
(10
/10
) M
d , *
*
0
0
0
1 
(8/
10
) M
c ,
*
D
S 
7.
89
/2
33
3 
m
on
th
s
2 
(5/
5) 
Df
,
*
*
1 
(5/
5) 
M
c
0
0
0
1 
(5/
5) 
M
c
D
S 
50
/2
33
3 
m
on
th
s
1.
4 
(5/
5) 
D
1.
4 
(5/
5) 
M
d , *
*
0
0
0.
6 
(3/
5) 
M
a ,
*
0.
8 
(3/
5) 
M
Lu
ng
 ti
ss
ue
 w
as
 a
n
al
yz
ed
 a
nd
 sc
or
ed
 fo
r a
cc
um
ul
at
io
n 
of
 a
lv
eo
la
r m
ac
ro
ph
ag
es
 a
s a
n 
in
de
x
 o
f i
nf
la
m
m
at
io
n 
(A
M
), a
lve
o
la
r e
pi
th
el
ia
l h
yp
er
pl
as
ia
 (A
EH
), b
ron
ch
us
 as
so
cia
ted
 ly
mp
ho
id 
tis
su
e h
yp
er
pl
as
ia
 
(B
H)
, ly
mp
ho
id 
no
du
les
 in
 th
e i
nte
rst
itiu
m 
(L
NI
), b
row
n
 g
ra
nu
le
s i
n 
al
ve
o
la
r m
ac
ro
ph
ag
es
 (B
G;
 th
e p
res
en
ce
 of
 D
PM
 pa
rti
cle
s),
 fib
ro
sis
 in
 a
lv
eo
la
r s
ep
ta
e 
(F
) (
n=
 5 
or 
10
 pe
r g
rou
p p
er 
tim
e p
oin
t).
 Se
v
er
ity
 
w
as
 s
co
re
d 
as
 0
–5
:0
=n
or
m
al
, 1
 =
m
in
im
al
/sl
ig
ht
, 2
 =
m
ild
, 3
=m
od
er
at
e,
4 
=m
ar
ke
d 
an
d 
5 
= 
se
v
er
e.
 In
ci
de
nc
e 
w
as
 n
o
te
d 
as
 F
o
ca
l (
F)
, M
ult
i-f
oc
al 
(M
), a
nd
 D
iff
us
e 
(D
). D
ata
 ar
e p
res
en
ted
 as
 m
ea
ns
 w
ith
 in
cid
en
ce
(nu
mb
er 
of 
an
im
als
 w
ith
 a 
po
sit
ive
 s
co
re
 p
er
 to
ta
l a
ni
m
al
s) 
in 
pa
re
nt
he
se
s.
a D
iff
er
en
t f
ro
m
 a
ll 
ot
he
r g
ro
up
s.
b D
iff
er
en
t f
ro
m
 c
on
tro
l a
nd
 D
PM
+5
0 
μg
 o
nl
y.
c D
iff
er
en
t f
ro
m
 c
on
tro
l o
nl
y.
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d D
iff
er
en
t f
ro
m
 c
on
tro
l, 
D
PM
+7
.8
9 
μg
, a
nd
 D
PM
+5
0 
μg
 g
ro
up
.
e D
iff
er
en
t f
ro
m
 c
on
tro
l a
nd
 S
IL
 2
33
 μ
g 
gr
ou
p.
f D
iff
er
en
t f
ro
m
 c
on
tro
l a
nd
 D
PM
+7
.8
9 
μg
 g
ro
up
.
A
ll 
no
ta
tio
ns
 in
di
ca
te
 a
 p
 v
al
ue
 <
.0
5 
ex
ce
pt
 w
he
re
 a
ste
ris
ks
 in
di
ca
te
*
p 
<
 .0
1 
an
d 
**
p 
<
 .0
5 
fo
r a
ll 
gr
ou
ps
 ex
ce
pt
 c
on
tro
l w
he
re
 p
 <
 .0
1.
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Ta
bl
e 
5.
Ly
m
ph
oc
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e 
ph
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e 
de
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in
at
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n 
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 fl
ow
 c
yt
om
et
ry
 in
 th
e 
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 re
co
v
er
ed
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 S
pr
ag
ue
-D
aw
le
y 
ra
ts 
ex
po
se
d 
to
 D
PM
, S
IL
 o
r D
PM
 a
nd
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IL
 
co
m
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ne
d 
w
ith
 L
M
. Ex
po
su
re
 (μ
g)
To
ta
l l
ym
ph
oc
yt
es
T 
ce
lls
C
D
4+
 
T 
ce
lls
C
D
8+
 
T 
ce
lls
B 
ce
lls
D
ay
-1
 p
os
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n
D
PM
 5
0
0.
19
 ±
 0
.2
2
−
0.
05
 ±
 0
.2
0
−
0.
04
 ±
 0
.2
0
−
0.
02
 ±
 0
.2
7
0.
17
 ±
 0
.3
2
SI
L 
23
3
0.
92
 ±
 0
.3
0@
0.
90
 ±
 0
.4
0
0.
89
 ±
 0
.3
7
0.
88
 ±
0.
51
0.
57
 ±
 0
.4
0
D
S 
50
/2
33
0.
52
 ±
 0
.2
3
0.
50
 ±
 0
.2
6
0.
48
 ±
 0
.2
7
0.
71
 ±
0.
38
0.
09
 ±
 0
.2
7
D
ay
-3
 p
os
tin
fe
ct
io
n
D
PM
 5
0
−
0.
07
 ±
 0
.1
7
−
0.
31
 ±
 0
.1
4
−
0.
17
 ±
 0
.1
8
−
0.
35
 ±
 0
.2
0
−
0.
15
 ±
 0
.1
1
SI
L 
23
3
−
0.
40
 ±
 0
.1
5
−
0.
48
 ±
 0
.0
9@
−
0.
30
 ±
 0
.0
8
−
0.
53
 ±
 0
.1
1
−
0.
40
 ±
 0
.1
1
D
S 
50
/2
33
−
0.
54
 ±
 0
.0
7
−
0.
59
 ±
 0
.0
5@
−
0.
33
 ±
 0
.0
7
−
0.
70
 ±
 0
.0
4@
−
0.
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 ±
 0
.0
5@
D
ay
-5
 p
os
tin
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io
n
D
PM
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0
0.
00
1 
± 
0.
21
−
0.
04
 ±
 0
.1
5
−
0.
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 ±
 0
.1
4
0.
03
 ±
 0
.1
6
0.
34
 ±
 0
.1
9
SI
L 
23
3
−
0.
25
 ±
 0
.1
7
−
0.
27
 ±
 0
.1
3
−
0.
40
 ±
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.1
0
−
0.
20
 ±
 0
.1
4
−
0.
07
 ±
 0
.2
4
D
S 
50
/2
33
−
0.
19
 ±
 0
.2
1
−
0.
15
 ±
 0
.2
4
−
0.
23
 ±
 0
.1
4
−
0.
12
 ±
 0
.3
1
−
0.
13
 ±
 0
.1
5
D
ay
-7
 p
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io
n
D
PM
 5
0
−
0.
03
 ±
 0
.1
2
0.
05
 ±
 0
.1
4
−
0.
02
 ±
 0
.1
2
−
0.
00
4 
± 
0.
14
−
0.
13
 ±
 0
.1
2
SI
L 
23
3
−
0.
15
 ±
 0
.1
0
−
0.
08
 ±
 0
.1
3
−
0.
17
 ±
 0
.1
0
−
0.
09
 ±
 0
.1
7
0.
10
 ±
 0
.2
1
D
S 
50
/2
33
−
0.
20
 ±
 0
.1
0
−
0.
19
 ±
 0
.1
1
−
0.
27
 ±
 0
.1
1
−
0.
17
 ±
 0
.1
5
−
0.
21
 ±
 0
.1
3
D
ay
-1
4 
po
sti
nf
ec
tio
n
D
PM
 5
0
0.
09
 ±
 0
.1
4
0.
17
 ±
 0
.2
1
0.
22
 ±
 0
.2
5
0.
18
 ±
 0
.1
7
0.
27
 ±
 0
.2
6
SI
L 
23
3
0.
89
 ±
 0
.2
0*
0.
65
 ±
 0
.2
3
1.
01
 ±
 0
.1
9
0.
89
 ±
 0
.3
6
−
0.
05
 ±
 0
.1
2
D
S 
50
/2
33
0.
95
 ±
 0
.2
6*
0.
80
 ±
 0
.2
9
1.
46
 ±
 0
.5
4*
0.
67
 ±
 0
.2
3
0.
00
2 
± 
0.
17
A
ll 
da
ta
 a
re
 sh
ow
n
 a
s 
m
ea
n
 fo
ld
 c
ha
ng
e 
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er
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o
n
tr
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 ±
 st
an
da
rd
 e
rro
r.
*
D
iff
er
en
t f
ro
m
 c
on
tro
l a
nd
 D
PM
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0 
μg
.
@
D
iff
er
en
t f
ro
m
 c
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tro
l. 
St
at
ist
ic
al
 si
gn
ifi
ca
nc
e 
is 
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.0
5.
Inhal Toxicol. Author manuscript; available in PMC 2019 June 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Farris et al. Page 35
Ta
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6.
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m
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yt
e 
ph
en
ot
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e 
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 fl
ow
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e 
M
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m
 S
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m
bi
ne
d 
w
ith
 L
M
. Ex
po
su
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l l
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D
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-1
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n
D
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0.
19
 ±
 0
.2
0
0.
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0.
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0.
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0.
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 ±
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D
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 ±
 0
.1
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0.
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 ±
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.1
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0.
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 ±
 0
.1
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0.
66
± 
0.
18
0.
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± 
0.
18
D
ay
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os
tin
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io
n
D
PM
 5
0
−
0.
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 ±
 0
.0
6
−
0.
18
 ±
 0
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7
−
0.
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 ±
 0
.0
8
−
0.
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± 
0.
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@
−
0.
19
 ±
 0
.0
6
SI
L 
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3
0.
26
 ±
 0
.1
0+
0.
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 ±
 0
.0
9^
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24
 ±
 0
.1
0
−
0.
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 ±
 0
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0.
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 ±
 0
.0
9
D
S 
50
/2
33
−
0.
08
 ±
 0
.0
8
−
0.
18
 ±
 0
.0
3
−
0.
04
 ±
 0
.0
2
−
0.
36
 ±
 0
.0
4@
−
0.
03
 ±
 0
.1
1
D
ay
 5
 p
os
tin
fe
ct
io
n
D
PM
 5
0
0.
40
 ±
 0
.1
6
0.
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 ±
 0
.1
5
0.
33
 ±
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.1
5
0.
38
 ±
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.1
5
0.
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 ±
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.2
2
SI
L 
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3
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 ±
 0
.1
0
0.
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 ±
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.1
0
0.
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.1
0
0.
04
 ±
 0
.1
2
0.
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 ±
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.0
9
D
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0.
32
 ±
 0
.1
4
0.
28
 ±
 0
.1
3
0.
28
 ±
 0
.1
4
0.
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 ±
 0
.1
2
0.
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 ±
 0
.2
1
D
ay
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 p
os
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fe
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n
D
PM
 5
0
0.
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 ±
 0
.2
7
0.
72
 ±
 0
.3
1
0.
76
 ±
 0
.3
1
0.
66
 ±
 0
.3
0
0.
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 ±
 0
.2
5
SI
L 
23
3
0.
30
 ±
 0
.2
0
0.
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 ±
 0
.2
3
0.
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 ±
 0
.2
5
0.
24
 ±
 0
.2
0
0.
25
 ±
 0
.1
8
D
S 
50
/2
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0.
40
 ±
0.
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0.
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 ±
 0
.1
6
0.
47
 ±
 0
.1
5
0.
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 ±
 0
.1
9
0.
40
 ±
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.1
6
D
ay
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4 
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n
D
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0
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 ±
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−
0.
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7
−
0.
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−
0.
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.2
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0.
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 ±
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.3
6
SI
L 
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3
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 ±
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0.
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 ±
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0.
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 ±
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.1
6
0.
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 ±
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.2
6
0.
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 ±
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.2
4
D
S 
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/2
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 ±
 0
.2
6
0.
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 ±
 0
.2
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0.
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 ±
 0
.3
0
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 ±
 0
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 ±
 0
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D
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er
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t f
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m
 c
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nd
 D
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0 
μg
.
@
D
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ro
m
 c
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tro
l.
^
D
iff
er
en
t f
ro
m
 D
PM
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0 
m
g 
an
d 
D
S 
50
/2
33
 μ
g 
gr
ou
ps
.
+
D
iff
er
en
t f
ro
m
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ll 
ot
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r g
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St
at
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gn
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5.
Inhal Toxicol. Author manuscript; available in PMC 2019 June 03.
